Wolfersdorf M, Barg T, König F, Leibfarth M, Grünewald I
Psychiatry Department I, University of Ulm, Weissenau Psychiatric Hospital, Ravensburg-Weissenau, Germany.
Pharmacopsychiatry. 1995 Mar;28(2):56-60. doi: 10.1055/s-2007-979589.
The combination of antidepressive and antipsychotic (neuroleptic) medication is often used in the psychopharmacological treatment of delusional depression. In most studies of the treatment of delusional depression, tricyclic antidepressants have been used, and very little has been written about experience with SSRIs such as fluvoxamine, fluoxetine, or paroxetine. This paper therefore presents the preliminary findings of an open clinical study in which 14 delusional depressed inpatients, consecutively admitted to our Depression Unit, were given paroxetine combined with either zotepine or haloperidol. It was possible to observe a significantly impressive decline in the HAMD (24-item version) total score, of so-called delusional items (HAMD subscore of items 2, 17, 18, 20, 23, 24) and of the subscore of remaining HAMD items over 21 treatment days. There were no unusual side-effects.
抗抑郁药与抗精神病药(神经阻滞剂)联合使用常用于妄想性抑郁症的精神药物治疗。在大多数关于妄想性抑郁症治疗的研究中,使用的是三环类抗抑郁药,而关于氟伏沙明、氟西汀或帕罗西汀等选择性5-羟色胺再摄取抑制剂(SSRI)的使用经验的报道却很少。因此,本文介绍了一项开放性临床研究的初步结果,该研究中,14名连续入住我们抑郁病房的妄想性抑郁症住院患者接受了帕罗西汀联合佐替平或氟哌啶醇的治疗。在21天的治疗过程中,观察到汉密尔顿抑郁量表(24项版本)总分、所谓的妄想项目(汉密尔顿抑郁量表第2、17、18、20、23、24项的子分数)以及汉密尔顿抑郁量表其余项目的子分数均显著下降。未出现异常副作用。